Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool

• Autori principali: Xiao-yi Bao (Autore), Qun Zheng (Autore), Qiang Tong (Autore), Peng-chong Zhu (Autore), Zhuang Zhuang (Autore), Guo-qing Zheng (Autore), Yan Wang (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2018-12-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Background: Danshensu (DSS) possesses unique bioactivity on the cardiovascular system. However, there is a lack of systematical summary of DSS for acute myocardial ischemia injury and no quality assessment tool for the systematical review of cell experiments. Here, we aimed to assess the preclinical...